TRYNGOLZA

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 71860-101
  • Package NDC 71860-101-01
  • Application number NDA218614
  • SPL ID 55b4730e-4610-c0f2-e063-6294a90a90ae
  • SPL set ID 0f51aa8e-8475-8cf9-e063-6394a90a6848
  • UNII NSY2BY6PSB
  • RxCUI 2701422
  • RxCUI 2701428
  • RxCUI 2746496
  • RxCUI 2746499

What the source publishes

Labeler
Ionis Pharmaceuticals, Inc.
Active ingredients
olezarsen sodium
Form
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:71860-101_55b4730e-4610-c0f2-e063-6294a90a90ae
{
  "name": "TRYNGOLZA",
  "splId": "55b4730e-4610-c0f2-e063-6294a90a90ae",
  "labels": [
    {
      "setId": "0f51aa8e-8475-8cf9-e063-6394a90a6848",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0f51aa8e-8475-8cf9-e063-6394a90a6848",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0f51aa8e-8475-8cf9-e063-6394a90a6848"
    }
  ],
  "routes": [
    "SUBCUTANEOUS"
  ],
  "labeler": "Ionis Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 SYRINGE, GLASS in 1 CARTON (71860-101-01)  / .8 mL in 1 SYRINGE, GLASS",
      "package_ndc": "71860-101-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20241219"
    }
  ],
  "productId": "71860-101_55b4730e-4610-c0f2-e063-6294a90a90ae",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION",
  "productNdc": "71860-101",
  "deaSchedule": null,
  "genericName": "olezarsen sodium",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "OLEZARSEN SODIUM",
      "strength": "80 mg/.8mL"
    }
  ],
  "applicationNumber": "NDA218614",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20241219",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "NSY2BY6PSB"
    ],
    "rxcui": [
      "2701422",
      "2701428",
      "2746496",
      "2746499"
    ],
    "spl_set_id": [
      "0f51aa8e-8475-8cf9-e063-6394a90a6848"
    ],
    "manufacturer_name": [
      "Ionis Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:71860-101_55b4730e-4610-c0f2-e063-6294a90a90ae"